Safe and effective systemic delivery of mRNA to specific organs and cells in vivo remains a significant challenge in the development of mRNA-based therapies. The rapid advancement of mRNA technology has transformed the landscape of vaccine development and gene therapy, yet its application is still predominantly limited to liver diseases. This limitation primarily arises from … Read more
Disclaimer:
We do not claim ownership of any content, links or images featured on this post unless explicitly stated. If you believe any content or images infringes on your copyright, please contact us immediately for removal (info@frobyn.com). Please note that content published under our account may be sponsored or contributed by guest authors. We assume no responsibility for the accuracy or originality of such content. We hold no responsibility for content and images published as ours is a publishers platform. Mail us for any query and we will remove that content/image immediately.